Tocilizumab for treating severe COVID‐19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series

Three patients diagnosed with severe COVID‐19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and survived. The thrid patient was diagnosed late and received...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Surabotsophon, Manoon, Klai‐On, Yingyot, Thanachartwet, Vipa, Khunapornphairote, Sirote, Chamnanchanunt, Supat, Racharak, Theerapat, Laisuan, Wannada, Sahassananda, Duangjai, Hapunna, Samlee, Jinapuk, Somjit, Leelasetakul, Suthee, Desakorn, Varunee
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675634/
https://ncbi.nlm.nih.gov/pubmed/33230415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados